A research team has computationally analyzed the expression of marker genes that are associated with a ‘fingerprint’ of cancer cells in thousands of tumors and revealed its therapeutic potential in the fight against cancer. The study shows the types of tumors in which these genes are most active and identifies drugs with the potential to selectively eliminate cells that carry that label.